Democrats, hospital group cheer Healthy Indiana Plan ruling
The top Democrat in the Indiana Senate is applauding the federal approval of Gov. Mike Pence's proposal for expansion of the Healthy Indiana Plan.
The top Democrat in the Indiana Senate is applauding the federal approval of Gov. Mike Pence's proposal for expansion of the Healthy Indiana Plan.
Federal officials have approved Indiana Gov. Mike Pence’s plan to provide health insurance to lower-income Hoosiers, despite provisions that require some participants to pay part of the premium.
When the U.S. Supreme Court hands down its ruling on Obamacare’s tax credits, it could zap nearly $1 billion from Hoosiers’ finances. In fact, Hoosiers buyers on Obamacare’s exchanges have more to lose, as a percentage of their incomes, than the residents of all states other than Alaska and Mississippi.
Bills aiming to reduce Indiana’s methamphetamine problem by requiring prescriptions for some cold medicines probably won’t be considered in House or Senate committees this session, key lawmakers said.
All signs point to University Hospital’s being shuttered as Indiana University Health goes from three downtown hospitals to two.
Two Democratic lawmakers have filed bills that would allow the use of medical marijuana in Indiana, although neither measure is likely to advance in the Republican-controlled Legislature.
The CEOs of Anthem, Lilly, Zimmer and Hill-Rom tried to woo investors at the J.P. Morgan Healthcare conference by stressing how they’re broadening business beyond plain-old insurance, pharmaceuticals, implants and hospital beds.
Nearly half of all Hoosier workers covered by employer health plans are now enrolled in high-deductible, consumer-directed health plans, according to a new survey. That means the state is about to pass the point of no return on transforming health care into a real marketplace.
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
That money toward Indiana University’s portion of the project is part of $50 million that IU and other schools involved in the project have requested from the state.
The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.
A division of CVS Pharmacy Inc. said it would consolidate work done at the facility to locations in Littleton, Colorado, and Jackson, Tennessee.
Recognizing that more and more Hoosier patients are trying to shop for health care, the Indiana Hospital Association has created a web tool with price and quality information for all hospitals around the state. But bigger changes to the health care system will be needed before consumers have the kind of information they expect in other industries.
Roughly 4 million uninsured people are expected to pay penalties, and 26 million could qualify for exemptions from a list of more than 30 waivers.
Indiana University Health officials are working on plans for building a new hospital in Bloomington to replace the system's aging facility.
The research is taking place as marijuana is gaining more acceptance in some parts of the nation, with pot now legalized for adult use in Colorado, Washington state, Alaska and Oregon.
The state Medicaid program will pay $24 million more due to the nursing home building boom that occurred in 2014, according to an analysis by accounting firm Myers & Stauffer. The nursing home industry will use that figure to once again argue for halt to new construction.
Eli Lilly and Co. wants to combine Novartis with its own animal health business, Elanco, to create the second-largest animal health company in the U.S.
WellPoint’s stock price rose 53 percent from Sept. 30, 2013—the day before the Obamacare insurance exchanges started up—until Dec. 19, 2014, when the price closed at $127.95.